SkinHealth Systems Inc. (SKIN)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 150M 300M 450M Q3 '21: 220.1M Q4 '21: 260.1M Q1 '22: 288M Q2 '22: 325M Q3 '22: 345.6M Q4 '22: 365.9M Q1 '23: 376.7M Q2 '23: 390.7M Q3 '23: 399.3M Q4 '23: 398M Q1 '24: 393.1M Q2 '24: 366.2M Q3 '24: 347.6M Q4 '24: 334.3M Q1 '25: 322.5M Q2 '25: 310.1M Q3 '25: 301.9M Q4 '25: 300.8M Q1 '26: 296.1M Q2 '26: 290M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 90M 180M 270M Q3 '21: 148.1M Q4 '21: 178.5M Q1 '22: 197.7M Q2 '22: 220.5M Q3 '22: 235.8M Q4 '22: 248.8M Q1 '23: 252M Q2 '23: 249.8M Q3 '23: 175.9M Q4 '23: 155.1M Q1 '24: 149.4M Q2 '24: 122.4M Q3 '24: 175.6M Q4 '24: 182.3M Q1 '25: 182.5M Q2 '25: 190.7M Q3 '25: 195.7M Q4 '25: 196.4M Q1 '26: 192.2M Q2 '26: 192.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

-150M -100M -50M 0 50M 100M 150M Q3 '21: -34.1M Q4 '21: -39.9M Q1 '22: -56.3M Q2 '22: -35M Q3 '22: -33.9M Q4 '22: -25.8M Q1 '23: -29.1M Q2 '23: -37.3M Q3 '23: -115M Q4 '23: -130.9M Q1 '24: -130.6M Q2 '24: -139.6M Q3 '24: -79M Q4 '24: -67.8M Q1 '25: -62.8M Q2 '25: -43.4M Q3 '25: -28.1M Q4 '25: -20.8M Q1 '26: -10.6M Q2 '26: -4.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-450M -300M -150M 0 150M 300M 450M Q3 '21: -396.7M Q4 '21: -378.8M Q1 '22: -344M Q2 '22: -198.3M Q3 '22: 16.7M Q4 '22: 44.2M Q1 '23: -7.5M Q2 '23: -10.4M Q3 '23: -84.2M Q4 '23: -100.1M Q1 '24: -80.5M Q2 '24: -83.7M Q3 '24: -28.2M Q4 '24: -29.1M Q1 '25: -38.5M Q2 '25: -19M Q3 '25: -11.7M Q4 '25: -9.5M Q1 '26: -6.1M Q2 '26: -28.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 90M 180M 270M Q3 '21: 72M Q4 '21: 81.5M Q1 '22: 90.3M Q2 '22: 104.5M Q3 '22: 109.9M Q4 '22: 117.1M Q1 '23: 124.7M Q2 '23: 140.8M Q3 '23: 223.4M Q4 '23: 242.9M Q1 '24: 243.7M Q2 '24: 243.8M Q3 '24: 172M Q4 '24: 152M Q1 '25: 140M Q2 '25: 119.4M Q3 '25: 106.2M Q4 '25: 104.4M Q1 '26: 103.9M Q2 '26: 97.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-120M -80M -40M 0 40M 80M 120M Q3 '21: -32.7M Q4 '21: -28.4M Q1 '22: -68.1M Q2 '22: -66.2M Q3 '22: -97.9M Q4 '22: -106.6M Q1 '23: -81.1M Q2 '23: -27.8M Q3 '23: 21.5M Q4 '23: 21.8M Q1 '24: 17.9M Q2 '24: 2.1M Q3 '24: -5.5M Q4 '24: 16.1M Q1 '25: 36M Q2 '25: 39.4M Q3 '25: 38.8M Q4 '25: 37.5M Q1 '26: 28.9M Q2 '26: 22M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-120M -80M -40M 0 40M 80M 120M Q3 '21: -38.5M Q4 '21: -39.6M Q1 '22: -81.6M Q2 '22: -78.3M Q3 '22: -114.2M Q4 '22: -117.4M Q1 '23: -91.2M Q2 '23: -36.7M Q3 '23: 16.8M Q4 '23: 17.9M Q1 '24: 16.1M Q2 '24: 1.3M Q3 '24: -6.2M Q4 '24: 15.4M Q1 '25: 35.5M Q2 '25: 39.2M Q3 '25: 38.5M Q4 '25: 37.2M Q1 '26: 28.5M Q2 '26: 21.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 60M 120M 180M Q2 '20: 34.5M Q3 '20: 35.4M Q1 '21: 35.5M Q2 '21: 91.8M Q3 '21: 132.3M Q1 '22: 152.7M Q2 '22: 151.7M Q3 '22: 151.4M Q1 '23: 132.4M Q2 '23: 132.7M Q3 '23: 132.9M Q1 '24: 144.5M Q2 '24: 141.9M Q3 '24: 124.1M Q1 '25: 125.1M Q2 '25: 140.3M Q3 '25: 126.9M Q1 '26: 131.4M Q2 '26: 129.6M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q2 '21: -1.82 Q3 '21: -3.45 Q4 '21: -3.71 Q1 '22: -3.75 Q2 '22: -2.29 Q3 '23: -0.69 Q4 '23: -0.76 Q2 '26: -0.21 Q2 '21 Q3 '21 Q4 '21 Q1 '22 Q2 '22 Q3 '23 Q4 '23 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.